Product Reports Resources Pricing Login Book a demo

CELLINK

Biotech & Life Sciences · Göteborgs Stad, Sweden · Founded 2016 · IPO 2016

The world’s leading bioconvergence company

Valuation $116M
Revenue $214M
EBITDA $15M

Talent graph

CELLINK's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

1 investor on CELLINK's cap table

Sourced from Dealroom's funding and investor records.

Seed 1 investor entered at this stage
Bosch Ventures

Global footprint

Where CELLINK has talent and traffic

Workforce by country
10 countries with
team presence
🇸🇪 Sweden67.7%
🇺🇸 United States19.6%
🇸🇬 Singapore3.7%
🇮🇳 India2.6%
🇪🇸 Spain2.1%
Top 5 of 10 shown
Web traffic by country
71K monthly visits
across markets
🇮🇳 India25.9%
🇮🇪 Ireland14.8%
🇺🇸 United States12.8%
🇸🇪 Sweden4.9%
🏳️ Korea4.6%
Top 5 markets shown

Patent intelligence

$84M patent portfolio · 141 active families

Estimated portfolio value
$84M
71.7% of market cap · 28.6× smaller than top peer Illumina ($2.4B)
141 active patent families
Where CELLINK innovates Physics3D bioprintingCellComputer printingMaterials science

Where CELLINK concentrates vs peers

Each axis is a top-10 topic across CELLINK and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

CELLINK's 8 investments and acquisitions.

Every disclosed deal where CELLINK appeared as a backer or acquirer, 2019–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

8 deals across CELLINK's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        CELLINK's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        8 of 8 deals

        Market sentiment

        What the market is saying about CELLINK

        An AI-synthesized read of the highest-engagement posts about CELLINK on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See CELLINK on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.